A afasia progressiva não fluente (APNF) é um tipo de demência frontotemporal (DFT). Ela se caracteriza por: dificuldade em montar frases com a gramática correta; fala arrastada e que exige muito esforço; dificuldade para ler; e dificuldade para escrever. Muitas vezes, vem acompanhada de apraxia da fala (AF), que é uma dificuldade em planejar os movimentos para falar. A capacidade de entender o que é dito ou lido costuma ser relativamente preservada.
Introdução
O que você precisa saber de cara
A afasia progressiva não fluente (APNF) é um tipo de demência frontotemporal (DFT). Ela se caracteriza por: dificuldade em montar frases com a gramática correta; fala arrastada e que exige muito esforço; dificuldade para ler; e dificuldade para escrever. Muitas vezes, vem acompanhada de apraxia da fala (AF), que é uma dificuldade em planejar os movimentos para falar. A capacidade de entender o que é dito ou lido costuma ser relativamente preservada.
Tem tratamento?
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 29 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 52 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
8 genes identificados com associação a esta condição. Padrão de herança: Multigenic/multifactorial, Not applicable.
Catalytic subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (amyloid-beta precursor protein) (PubMed:10206644, PubMed:10545183, PubMed:10593990, PubMed:10811883, PubMed:10899933, PubMed:12679784, PubMed:12740439, PubMed:15274632, PubMed:20460383, PubMed:25043039, PubMed:26280335, PubMed:28269784, PubMed:30598546, PubMed:30630874). Requires the presence of the other members of the
Endoplasmic reticulumEndoplasmic reticulum membraneGolgi apparatus membraneCytoplasmic granuleCell membraneCell projection, growth coneEarly endosomeEarly endosome membraneCell projection, neuron projectionCell projection, axonSynapse
Alzheimer disease 3
A familial early-onset form of Alzheimer disease. Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death.
Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isofo
Cytoplasm, cytosolCell membraneCytoplasm, cytoskeletonCell projection, axonCell projection, dendriteSecreted
Acts as a guanine-nucleotide releasing factor (GEF) for Rab GTPases by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP (PubMed:27103069, PubMed:27193190, PubMed:27617292, PubMed:28195531, PubMed:37821429). Acts as a GEF for RAB39A which enables HOPS-mediated autophagosome-lysosome membrane tethering and fusion in mammalian autophagy (PubMed:37821429). Component of the C9orf72-SMCR8 complex where both subunits display GEF activity and that regulates autophagy (PubMed:27103
CytoplasmNucleusCytoplasm, P-bodyCytoplasm, Stress granuleEndosomeLysosomeCytoplasmic vesicle, autophagosomeAutolysosomeSecretedCell projection, axonCell projection, growth conePerikaryonCell projection, dendritePresynapsePostsynapseNucleus membrane
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
An autosomal dominant neurodegenerative disorder characterized by adult onset of frontotemporal dementia and/or amyotrophic lateral sclerosis in an affected individual. There is high intrafamilial variation. Frontotemporal dementia is characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Amyotrophic lateral sclerosis is characterized by the death of motor neurons in the brain, brainstem, and spinal cord, resulting in fatal paralysis.
Forms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding (PubMed:10799849). Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor protein APP, and mediates its uptake and degradation by microglia (PubMed:27477018, PubMed:29518356). Binding to amyloid-beta 42 mediates microglial activation, proliferation, migration, apoptosis and expression of pro-inflammatory cytokines, such as IL6R and CCL3, a
Cell membraneSecreted
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2
An autosomal recessive disease characterized by presenile frontal dementia with leukoencephalopathy and basal ganglia calcification. In most cases the disorder first manifests in early adulthood as pain and swelling in ankles and feet, followed by bone fractures. Neurologic symptoms manifest in the fourth decade of life as a frontal lobe syndrome with loss of judgment, euphoria, and disinhibition. Progressive decline in other cognitive domains begins to develop at about the same time. The disorder culminates in a profound dementia and death by age 50 years.
Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The M
Cytoplasm, cytosolLate endosome membrane
Frontotemporal dementia and/or amyotrophic lateral sclerosis 7
A neurodegenerative disorder characterized by frontotemporal dementia and/or amyotrophic lateral sclerosis in affected individuals. There is high intrafamilial variation. Frontotemporal dementia (FTD) is characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Amyotrophic lateral sclerosis (ALS) is characterized by the death of motor neurons in the brain, brainstem, and spinal cord, resulting in fatal paralysis. FTDALS7 is an autosomal dominant form characterized by onset of ALS or FTD in adulthood. A few patients may have both phenotypes.
Necessary for the fragmentation of Golgi stacks during mitosis and for their reassembly after mitosis. Involved in the formation of the transitional endoplasmic reticulum (tER). The transfer of membranes from the endoplasmic reticulum to the Golgi apparatus occurs via 50-70 nm transition vesicles which derive from part-rough, part-smooth transitional elements of the endoplasmic reticulum (tER). Vesicle budding from the tER is an ATP-dependent process. The ternary complex containing UFD1, VCP and
Cytoplasm, cytosolEndoplasmic reticulumNucleusCytoplasm, Stress granule
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance.
In neurons, involved in the transport of late endosomes/lysosomes (PubMed:25066864). May be involved in dendrite morphogenesis and maintenance by regulating lysosomal trafficking (PubMed:25066864). May act as a molecular brake for retrograde transport of late endosomes/lysosomes, possibly via its interaction with MAP6 (By similarity). In motoneurons, may mediate the axonal transport of lysosomes and axonal sorting at the initial segment (By similarity). It remains unclear whether TMEM106B affect
Late endosome membraneLysosome membraneCell membrane
Frontotemporal dementia 2
A form of dementia characterized by pathologic finding of frontotemporal lobar degeneration, presenile dementia with behavioral changes, deterioration of cognitive capacities and loss of memory. Gestural apraxia, parkinsonism, visual loss, and visual hallucinations are present in 25 to 40% of patients.
Secreted protein that acts as a key regulator of lysosomal function and as a growth factor involved in inflammation, wound healing and cell proliferation (PubMed:12526812, PubMed:18378771, PubMed:28073925, PubMed:28453791, PubMed:28541286). Regulates protein trafficking to lysosomes, and also the activity of lysosomal enzymes (PubMed:28453791, PubMed:28541286). Also facilitates the acidification of lysosomes, causing degradation of mature CTSD by CTSB (PubMed:28073925). In addition, functions as
SecretedLysosome
Frontotemporal dementia 2
A form of dementia characterized by pathologic finding of frontotemporal lobar degeneration, presenile dementia with behavioral changes, deterioration of cognitive capacities and loss of memory. Gestural apraxia, parkinsonism, visual loss, and visual hallucinations are present in 25 to 40% of patients.
Medicamentos e terapias
Mecanismo: Myeloperoxidase inhibitor
Variantes genéticas (ClinVar)
433 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 1 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
51 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Afasia, progressiva primária, tipo não-fluente
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
🟢 Recrutando agora
8 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
20 ensaios clínicos encontrados, 9 ativos.
Publicações mais relevantes
Behavioural rigidity as a transdiagnostic marker of nucleus accumbens dysfunction in dementia.
Behavioural rigidity, the tendency to persist with inflexible patterns of thoughts or actions, is increasingly recognised as a transdiagnostic symptom across psychiatric, neurodevelopmental, and neurodegenerative disorders. Empirical studies exploring the prevalence and underlying neural mechanisms of behavioural rigidity in dementia, however, are lacking. This cross-sectional study sought to delineate the structural and functional neural correlates of behavioural rigidity using a transdiagnostic approach looking across the frontotemporal lobar degeneration (FTLD) spectrum and Alzheimer's disease. A total of 204 participants were recruited, including 110 frontotemporal dementia (FTD), 53 Alzheimer's disease (AD), and 41 healthy older control participants. Within the FTD group, 66 cases were diagnosed with clinically probable behavioural variant FTD (bvFTD), 26 presented with semantic dementia (SD), and 18 cases had progressive non-fluent aphasia (PNFA). Behavioural rigidity was assessed using the Stereotypical and Motor Behaviour subscale of the Cambridge Behavioural Inventory-Revised. Voxel-based morphometry (VBM) was performed to identify grey matter regions associated with behavioural rigidity transdiagnostically, the results of which informed subsequent seed-based voxel-wise functional connectivity analyses. All imaging analyses were adjusted for relevant demographic and technical covariates. Statistical thresholds were set at voxel-level p < 0.001 (uncorrected) and cluster-level p < 0.05 (FDR-corrected). Our main finding was that behavioural rigidity is pervasive across dementia subtypes, ranging from most pronounced in bvFTD to milder/relatively absent in PNFA, relative to Controls. Whole-brain VBM across the entire patient sample revealed a significant negative association between behavioural rigidity and grey matter intensity exclusively in the bilateral nucleus accumbens. Using the bilateral nucleus accumbens as seeds, resting-state functional connectivity analysis showed that higher levels of behavioural rigidity were associated with stronger connectivity between the left nucleus accumbens and the left supplementary motor area, paracentral lobule, and precuneus. This is the first study, to our knowledge, to examine the neural substrates of behavioural rigidity across FTLD syndromes transdiagnostically using structural and functional neuroimaging approaches. Our findings reveal a gradation of rigid and repetitive behaviours, most apparent in bvFTD, which in turn reflects pathological disruption of the nucleus accumbens. Taken together, our findings highlight the need to consider repetitive and rigid behaviours as a transdiagnostic feature in neurodegenerative disorders, and one which indexes underlying nucleus accumbens pathology. More broadly, this study underscores the importance of screening for rigid and repetitive behaviours in the clinic and identifies the nucleus accumbens as a promising neural target to ameliorate these symptoms.
Connectome-based markers predict the sub-types of frontotemporal dementia.
Frontotemporal dementia (FTD) presents a complex spectrum of neurodegenerative disorders, encompassing distinct subtypes with varied clinical manifestations. This study investigates alterations in brain module organization associated with FTD subtypes using connectome analysis, aiming to identify potential biomarkers and enhance subtype prediction. Resting-state functional magnetic resonance imaging data were obtained from 41 individuals with behavioral variant frontotemporal dementia (BV-FTD), 32 with semantic variant frontotemporal dementia (SV-FTD), 28 with progressive non-fluent aphasia frontotemporal dementia (PNFA-FTD), and 94 healthy controls. Individual functional brain networks were constructed at the voxel level and binarized based on density thresholds. Modular segregation index (MSI) and participation coefficient (PC) were calculated to assess module integrity and identify regions with altered nodal properties. The relationship between modular measures and clinical scores was examined, and machine learning models were developed for subtype prediction. Both BV-FTD and SV-FTD groups exhibited decreased MSI in the subcortical module (SUB), default mode network (DMN), and ventral attention network (VAN) compared to healthy controls. Additionally, BV-FTD specifically displayed disrupted frontoparietal network (FPN) integrity compared to other FTD subtypes and controls. All FTD subtypes showed increased PC values in the insular region and reduced connections between the insular and VAN/FPN compared to controls. Moreover, significant associations between specific network alterations and clinical variables were observed. Machine learning models utilizing these matrices achieved high performance in differentiating FTD subtypes. This pilot study reveals diverse brain module organization across FTD subtypes, shedding light on both shared and distinct neurobiological underpinnings of the disorder.
Unspoken art: progressive non-fluent aphasia in a painter.
[Classification and Clinical Characteristics of Dementia].
Community-based surveys conducted in Japan investigating the prevalence of dementia and its underlying causes revealed that dementia of Alzheimer's type (DAT) is the most common, followed by vascular dementia (VaD), dementia with Lewy bodies (DLB), mixed dementia, and other conditions including frontotemporal lobar degeneration (FTLD). Accurate differential diagnosis of these disorders requires clarification of their clinical characteristics. The initial symptoms of DAT typically include recent memory loss, episodic memory impairment, and temporal disorientation. Behavioral and psychological symptoms often observed in DAT include delusions of theft, "saving appearance" responses, and head-turning signs. Vascular dementia develops in association with cerebrovascular disease and frequently exhibits a stepwise progression. DLB is characterized by core clinical features such as cognitive fluctuations, visual hallucinations, parkinsonism, and REM sleep behavior disorder. Diagnostic tools such as 123Iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and dopamine transporter (DAT) imaging may aid in diagnosis. In Parkinson's disease with dementia (PDD), cognitive impairment appears more than one year after the onset of parkinsonism. FTLD involves degeneration of the frontal and temporal lobes, leading to prominent changes in personality, behavior, and language function. Several subtypes of FTLD exist depending on the affected brain region, including the behavioral variant of frontotemporal dementia, semantic dementia, and progressive non-fluent aphasia. Idiopathic normal-pressure hydrocephalus (iNPH) is characterized by gait disturbance, urinary incontinence, and dementia, resulting from an abnormal accumulation of cerebrospinal fluid. Pathologically confirmed cases of DLB and progressive supranuclear palsy (PSP) may occasionally present with symptoms resembling iNPH.
A Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditions.
Timely diagnosis is crucial for managing neurodegenerative conditions. This study investigated whether time from symptom onset to diagnosis differs by clinical syndrome and sex. This retrospective, cross-sectional study included 591 participants with Alzheimer's disease (AD), frontotemporal dementia (FTD) subtypes (behavioral variant FTD [bvFTD], semantic dementia [SD], and progressive non-fluent aphasia), logopenic progressive aphasia (LPA), and syndromes associated with movement disorders (corticobasal syndrome, FTD with motor neuron disease [FTD-MND], and progressive supranuclear palsy). Bayesian regression models were used to compute diagnostic timelines. Compared to AD (3.35 years; 95% credible interval [CrI]: 3.03-3.72), SD and bvFTD had additional delays of 9.7 (95% CrI: 1.96-20.64) and 14.82 months (95% CrI: 6.94-25.42), respectively, while FTD-MND was shorter by 11.62 months (95% CrI: -15.7 to -4.68). Men with bvFTD had 23.64 month longer delays than women (95% CrI: 10.35-44.33). Diagnostic delays may reflect syndrome-specific clinical features, diagnostic complexity, and sociocultural factors. Findings highlight the need for improved diagnostic pathways and pre-clinical biomarkers to facilitate earlier identification. Bayesian analyses revealed that diagnostic delays differ by syndrome and sex.Alzheimer's disease (AD) was diagnosed on average 3.35 years after symptom onset.Diagnoses were delayed in semantic and behavioral variant frontotemporal dementia (bvFTD) compared to AD.Men with bvFTD had longer delays than women.Findings support need for improved diagnostic pathways and pre-clinical biomarkers.
Publicações recentes
Behavioural rigidity as a transdiagnostic marker of nucleus accumbens dysfunction in dementia.
Unspoken art: progressive non-fluent aphasia in a painter.
Connectome-based markers predict the sub-types of frontotemporal dementia.
[Classification and Clinical Characteristics of Dementia].
A Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditions.
📚 EuropePMC29 artigos no totalmostrando 62
Behavioural rigidity as a transdiagnostic marker of nucleus accumbens dysfunction in dementia.
Brain : a journal of neurologyUnspoken art: progressive non-fluent aphasia in a painter.
Practical neurologyConnectome-based markers predict the sub-types of frontotemporal dementia.
Molecular psychiatry[Classification and Clinical Characteristics of Dementia].
No shinkei geka. Neurological surgeryA Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditions.
Alzheimer's & dementia (Amsterdam, Netherlands)Anatomy-Guided Microsurgical Resection of a Dominant Frontal Lobe Tumor Without Intraoperative Adjuncts: A Case Report from a Resource-Limited Context.
Diagnostics (Basel, Switzerland)Case report: Behavioral variant FTD confounding a language variant FTD in a case of PSP-CBS.
Frontiers in dementiaClinical and cortical trajectories in non-fluent primary progressive aphasia and Alzheimer's disease: A role for emotion processing.
Brain researchError profiles of facial emotion recognition in frontotemporal dementia and Alzheimer's disease.
International psychogeriatricsAnalysis of positron emission tomography hypometabolic patterns and neuropsychiatric symptoms in patients with dementia syndromes.
CNS neuroscience & therapeuticsAnatomical MRI staging of frontotemporal dementia variants.
Alzheimer's & dementia : the journal of the Alzheimer's AssociationAmyotrophic lateral sclerosis with primary progressive aphasia: a case report and literature review.
Neuro endocrinology lettersShouting from far away: three poems about living with speechlessness.
Practical neurology[A case of non-fluent/agrammatic variant of primary progressive aphasia with logoclonia].
Rinsho shinkeigaku = Clinical neurologyA Patient with Corticobasal Syndrome and Progressive Non-Fluent Aphasia (CBS-PNFA), with Variants in ATP7B, SETX, SORL1, and FOXP1 Genes.
GenesRemote versus face-to-face neuropsychological testing for dementia research: a comparative study in people with Alzheimer's disease, frontotemporal dementia and healthy older individuals.
BMJ openPrimary progressive aphasia and motor neuron disease: A review.
Frontiers in aging neuroscienceOlfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease.
Journal of Alzheimer's disease : JADAnosognosia in Dementia: Evaluation of Perfusion Correlates Using 99mTc-HMPAO SPECT and Automated Brodmann Areas Analysis.
Diagnostics (Basel, Switzerland)Biological basis and psychiatric symptoms in frontotemporal dementia.
Psychiatry and clinical neurosciencesCognitive and Neural Mechanisms of Social Communication Dysfunction in Primary Progressive Aphasia.
Brain sciencesCharacteristics of behavioral symptoms in right-sided predominant semantic dementia and their impact on caregiver burden: a cross-sectional study.
Alzheimer's research & therapySemantic memory impairment in dementia: A cross-cultural adaptation study.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyUncovering the prevalence and neural substrates of anhedonia in frontotemporal dementia.
Brain : a journal of neurologyCase of early-onset Alzheimer's disease with atypical manifestation.
General psychiatrySocial Cognition Deficits Are Pervasive across Both Classical and Overlap Frontotemporal Dementia Syndromes.
Dementia and geriatric cognitive disorders extraExamining prefrontal contributions to past- and future-oriented memory disturbances in daily life in dementia.
Cortex; a journal devoted to the study of the nervous system and behaviorClassification of general and personal semantic details in the Autobiographical Interview.
Neuropsychologia[Amyotrophic Lateral Sclerosis and Frontotemporal Dementia].
Brain and nerve = Shinkei kenkyu no shinpoSustained attention failures on a 3-min reaction time task is a sensitive marker of dementia.
Journal of neurologyClinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.
Journal of neurologyNetwork localization of heterogeneous neuroimaging findings.
Brain : a journal of neurologyA meta-analysis of neuropsychological, social cognitive, and olfactory functioning in the behavioral and language variants of frontotemporal dementia.
Psychological medicineRemarkable behavioural signs and progressive non-fluent aphasia in a patient with adult-onset leucoencephalopathy with axonal spheroids and pigmented glia.
Psychogeriatrics : the official journal of the Japanese Psychogeriatric SocietyRole of Positron Emission Tomography as a Biologic Marker in the Diagnosis of Primary Progressive Aphasia: Two Case Reports.
Nuclear medicine and molecular imagingA case of progressive non-fluent aphasia as onset of amyotrophic lateral sclerosis with frontotemporal dementia.
The International journal of neurosciencePathogenesis of Frontotemporal Lobar Degeneration: Insights From Loss of Function Theory and Early Involvement of the Caudate Nucleus.
Frontiers in neuroscienceRetained capacity for perceptual learning of degraded speech in primary progressive aphasia and Alzheimer's disease.
Alzheimer's research & therapyCSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms?
Frontiers in neurology[Neuropathologic Subtypes of Frontotemporal Lobar Degeneration].
Brain and nerve = Shinkei kenkyu no shinpoCerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
Alzheimer's research & therapyVestibular symptoms as the presenting feature of progressive supranuclear palsy.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of AustralasiaAphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.
Journal of Alzheimer's disease : JADMusic models aberrant rule decoding and reward valuation in dementia.
Social cognitive and affective neuroscienceBehavioural and neuroanatomical correlates of auditory speech analysis in primary progressive aphasias.
Alzheimer's research & therapySemantic dementia, progressive non-fluent aphasia and their association with amyotrophic lateral sclerosis.
Journal of neurology, neurosurgery, and psychiatryThe midbrain-to-pons ratio distinguishes progressive supranuclear palsy from non-fluent primary progressive aphasias.
European journal of neurologyA case of TREM2 mutation presenting with features of progressive non-fluent aphasia and without bone involvement.
The Australian and New Zealand journal of psychiatrySporadic Creutzfeldt-Jakob disease presenting with isolated progressive non-fluent aphasia in a young woman.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyGene-based association studies report genetic links for clinical subtypes of frontotemporal dementia.
Brain : a journal of neurologyPredicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia.
Journal of Alzheimer's disease : JADBehavioural and neuropsychiatric disturbance in three clinical subtypes of frontotemporal dementia: A Clinical Research Center for Dementia of South Korea-FTD Study.
Australasian journal on ageingFrontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
Brain pathology (Zurich, Switzerland)Familial Creutzfeldt-Jakob Disease: Case report and role of genetic counseling in post mortem testing.
PrionCore auditory processing deficits in primary progressive aphasia.
Brain : a journal of neurologySurvival in Frontotemporal Dementia Phenotypes: A Meta-Analysis.
Dementia and geriatric cognitive disordersPain and temperature processing in dementia: a clinical and neuroanatomical analysis.
Brain : a journal of neurologyThe frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
Parkinsonism & related disordersWriting in Richardson variant of progressive supranuclear palsy in comparison to progressive non-fluent aphasia.
Neurologia i neurochirurgia polskaAtypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein.
Acta neuropathologica[Current concepts regarding cortical dementia].
Brain and nerve = Shinkei kenkyu no shinpoClinical and Neuropsychological Comparisons of Early-Onset Versus Late-Onset Frontotemporal Dementia: A CREDOS-FTD Study.
Journal of Alzheimer's disease : JADAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Afasia, progressiva primária, tipo não-fluente.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Afasia, progressiva primária, tipo não-fluente
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Behavioural rigidity as a transdiagnostic marker of nucleus accumbens dysfunction in dementia.
- Connectome-based markers predict the sub-types of frontotemporal dementia.
- Unspoken art: progressive non-fluent aphasia in a painter.
- [Classification and Clinical Characteristics of Dementia].
- A Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditions.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:100070(Orphanet)
- MONDO:0015059(MONDO)
- GARD:10793(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Q18583(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
